188 related articles for article (PubMed ID: 10825921)
1. No acute varicella-zoster virus replication in peripheral blood mononuclear cells during postherpetic neuralgia.
Schünemann S; Mainka C; Wolff MH
Acta Virol; 1999 Dec; 43(6):337-40. PubMed ID: 10825921
[TBL] [Abstract][Full Text] [Related]
2. Acyclovir treatment prevents varicella-zoster virus replication in PBMC during viremia.
Wolff MH; Schünemann S
New Microbiol; 1999 Oct; 22(4):309-14. PubMed ID: 10555200
[TBL] [Abstract][Full Text] [Related]
3. Brief presence of varicella-zoster vral DNA in mononuclear cells during relapses of multiple sclerosis.
Ordoñez G; Pineda B; Garcia-Navarrete R; Sotelo J
Arch Neurol; 2004 Apr; 61(4):529-32. PubMed ID: 15096401
[TBL] [Abstract][Full Text] [Related]
4. Characterization of viremia at different stages of varicella-zoster virus infection.
Mainka C; Fuss B; Geiger H; Höfelmayr H; Wolff MH
J Med Virol; 1998 Sep; 56(1):91-8. PubMed ID: 9700639
[TBL] [Abstract][Full Text] [Related]
5. Detection of varicella-zoster virus DNA in peripheral mononuclear cells from patients with Ramsay Hunt syndrome or zoster sine herpete.
Terada K; Niizuma T; Kawano S; Kataoka N; Akisada T; Orita Y
J Med Virol; 1998 Dec; 56(4):359-63. PubMed ID: 9829642
[TBL] [Abstract][Full Text] [Related]
6. Expression of varicella-zoster virus in blood mononuclear cells of patients with postherpetic neuralgia.
Vafai A; Wellish M; Gilden DH
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2767-70. PubMed ID: 2833752
[TBL] [Abstract][Full Text] [Related]
7. Varicella zoster virus: natural history and current therapies of varicella and herpes zoster.
Breuer J; Whitley R
Herpes; 2007 Sep; 14 Suppl 2():25-9. PubMed ID: 17939892
[TBL] [Abstract][Full Text] [Related]
8. Varicella virus-mononuclear cell interaction.
White TM; Gilden DH
Adv Virus Res; 2003; 62():1-17. PubMed ID: 14719363
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis of the leftward end of simian varicella virus (EcoRI-I fragment) reveals the presence of an 8-bp repeat flanking the unique long segment and an 881-bp open-reading frame that is absent in the varicella zoster virus genome.
Mahalingam R; White T; Wellish M; Gilden DH; Soike K; Gray WL
Virology; 2000 Sep; 274(2):420-8. PubMed ID: 10964784
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis.
Mancuso R; Delbue S; Borghi E; Pagani E; Calvo MG; Caputo D; Granieri E; Ferrante P
J Med Virol; 2007 Feb; 79(2):192-9. PubMed ID: 17177306
[TBL] [Abstract][Full Text] [Related]
11. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
12. Infectibility of separated peripheral blood mononuclear cell subpopulations by varicella-zoster virus (VZV).
Koenig A; Wolff MH
J Med Virol; 2003; 70 Suppl 1():S59-63. PubMed ID: 12627490
[TBL] [Abstract][Full Text] [Related]
13. Varicella-Zoster virus proteins encoded by open reading frames 14 and 67 are both dispensable for the establishment of latency in a rat model.
Grinfeld E; Sadzot-Delvaux C; Kennedy PG
Virology; 2004 May; 323(1):85-90. PubMed ID: 15165821
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
15. Effect of viral load on the outcome of herpes zoster.
Quinlivan ML; Ayres K; Ran H; McElwaine S; Leedham-Green M; Scott FT; Johnson RW; Breuer J
J Clin Microbiol; 2007 Dec; 45(12):3909-14. PubMed ID: 17855575
[TBL] [Abstract][Full Text] [Related]
16. Rapid contamination of the environments with varicella-zoster virus DNA from a patient with herpes zoster.
Yoshikawa T; Ihira M; Suzuki K; Suga S; Tomitaka A; Ueda H; Asano Y
J Med Virol; 2001 Jan; 63(1):64-6. PubMed ID: 11130889
[TBL] [Abstract][Full Text] [Related]
17. Molecular and therapeutic aspects of varicella-zoster virus infection.
Quinlivan M; Breuer J
Expert Rev Mol Med; 2005 Aug; 7(15):1-24. PubMed ID: 16098235
[TBL] [Abstract][Full Text] [Related]
18. VZV vasculopathy and postherpetic neuralgia: progress and perspective on antiviral therapy.
Gilden DH; Cohrs RJ; Mahalingam R
Neurology; 2005 Jan; 64(1):21-5. PubMed ID: 15642898
[TBL] [Abstract][Full Text] [Related]
19. Varicella-Zoster virus gene expression in latently infected rat dorsal root ganglia.
Kennedy PG; Grinfeld E; Bontems S; Sadzot-Delvaux C
Virology; 2001 Oct; 289(2):218-23. PubMed ID: 11689044
[TBL] [Abstract][Full Text] [Related]
20. Varicella-zoster virus infection of a human CD4-positive T-cell line.
Zerboni L; Sommer M; Ware CF; Arvin AM
Virology; 2000 May; 270(2):278-85. PubMed ID: 10792986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
